Members of the public who spend a significant amount of time with chickens or other birds are being encouraged to sign up for ...

A first-of-its-kind trial has been launched to test a new vaccine for bird flu in humans. Thousands of people in the UK are ...

An mRNA vaccine for avian influenza, developed by pharma company Moderna, has begun Phase 3 human trials. Building on the ...

Bird flu mRNA vaccine advances to Phase 3 testing with 4,000 participants. Discover how Moderna's H5N1 vaccine could ...

Bird flu vaccine trial begins to fight ‘real possibility’ of virus threat for humans - The vaccine will utilise mRNA ...

The American pharmaceutical and biotechnology company Moderna has initiated a large clinical trial around a vaccine designed ...

Many humans may already have some immunity to H5N1 bird flu, raising hopes that the virus could pose less of a threat than ...

A landmark Phase 3 trial has begun in the UK and US to test Moderna’s mRNA-1018 vaccine against the H5N1 bird flu strain, a virus with pandemic potential. The study will assess safety and immune ...

The findings show how the H5N1 bird flu virus is evolving in livestock and what that may mean for human health.

The state's first outbreak of highly pathogenic avian influenza for 2026, known as HPAI or bird flu, in a commercial flock ...

The disease has spread across Indiana, wreaking havoc for poultry producers. However, response has been swift and producers ...